The experience of encountering advertising tailored to one?s behaviors or interests on the internet has become ubiquitous in a very short time. We?ve all had that experience ? shopping for a particular shoe on Zappos or gadget on Amazon, not buying it, then having an ad for that shoe or that gadget magically appear in […]
Author Archive | admin
By admin
December 17, 2011
Register for GOLD – Best Value for the DTC National 2012
The DTC National Gold Pass is the ‘Best Value’ Option for Attendees interested in the full DTC National experience. From streamlining the check-in process to post-conference access of the conference videos, the Gold Pass includes a great bundle of conference elements. Attend the pre-conference workshop on targetted DTC marketing options and use your $199 […]
By admin
August 19, 2008
Bob Ehrlich?s blog on blogs – August 19, 2008
John Mack in his Pharma Marketing Blog of 8/14 wrote an interesting piece called Rethinking the Value of DTC Advertising . Mack says that the numbers of patients who visit and ask doctors about advertised drugs is very low. Therefore, he wonders how the expenditures can pay back on this low a number of patient […]
By admin
July 29, 2008
Bob Ehrlich's blog on blogs – July 29, 2008
Cliff Mintz in BioJobBlog (July 12) says pharma has discovered You Tube in a big way. He says many drug companies are using it to post ads, educational videos and creating contests for consumers to create videos on what it is like to have certain diseases. He singles out J&J saying ?these pharma assaults on […]
By admin
June 16, 2008
blogspectives June 16, 2008
Ed Silverman in Pharmalot (June 11) comments on the FDA’s report that the biggest reporter of adverse events is now the consumer, not the doctor. In 2007, consumers reported 174,000 events versus only 121,000 from doctors. My take is that part of the reason consumers report more adverse events is familiarity with the side effects […]
By admin
June 2, 2008
blogspectives – June 2, 2008
Welcome to our first issue of Blogspectives. Bi-weekly I will comment on health blogs that discuss pharmaceutical marketing, public policy, and consumer trends and behavior. This is not a blog recap per se, but my editorial spin, comment, rebuttal or agreement with those bloggers. I scan what I believe are relevant blogs to the DTC […]
